AU Patent

AU2011265294B2 — Nanoparticle film delivery systems

Assigned to Midatech Ltd · Expires 2015-01-22 · 11y expired

What this patent protects

A therapeutic or bioeffecting film delivery system which includes nanoparticles having actives bound to or associated with the nanoparticles and which when administered allow the active to perform a therapeutic or bioeffecting function.

USPTO Abstract

A therapeutic or bioeffecting film delivery system which includes nanoparticles having actives bound to or associated with the nanoparticles and which when administered allow the active to perform a therapeutic or bioeffecting function.

Drugs covered by this patent

chembl-chembl2106195 (DEXMEDETOMIDINE HYDROCHLORIDE)

Patent Metadata

Patent number: AU2011265294B2
Jurisdiction: AU
Classification: —
Expires: 2015-01-22
Drug substance claim: No
Drug product claim: No
Assignee: Midatech Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.